Le Lézard
Classified in: Health
Subjects: SVY, SCZ, AVO, CFG

Canadian seniors take too many risky medications: we are taking action to change this at the "Making Meds Safer for Older Adults" Maritimes stakeholder event


MONCTON, Sept. 24, 2019 /CNW/ - Equal access to prescription medications is a hot topic in the 2019 Canadian federal elections. But access to prescription medications is only part of the story. Some prescription medications we take can potentially do more harm than good, these are called risky medications.

Logo: Canadian Deprescribing Network (CNW Group/Canadian Deprescribing Network)

Seniors are particularly vulnerable to the side-effects of risky medications, which include falls, fractures, confusion, hospitalizations and loss of independence. On average, 49% of Canadians take risky prescription medications (CIHI 2018).

When it comes to risky medication use, not all Canadian provinces are equal. For example:

We are taking action to change these statistics:

The Canadian Deprescribing Network is hosting Making Meds Safer for Older Adults, a bilingual event taking place on September 27th in Moncton, N.B. The event will bring together community organizations, healthcare providers, researchers and government representatives. Lead experts will present evidence-based strategies to reduce the use of risky medications. The goal? Make medication use safer for seniors in the Maritimes.

"The stats are alarming. Too many seniors are not aware that some of the medications they take could cause them harm. It's time we start taking this seriously." Bill Berryman, President of the Retired Teachers Organization of Nova Scotia and a member of the event planning committee.

Making Meds Safer for Older Adults is being held on September 27th from 9AM to 3:30PM at the Four Points by Sheraton (40 Lady Ada Blvd, Moncton, NB). Speakers and participants will be available for interviews.

The Canadian Deprescribing Network (CaDeN) is a group of patient advocates, healthcare leaders, decision-makers, and researchers working together to mobilize knowledge and promote the deprescribing of medications that may no longer be of benefit or may be causing harm. CaDeN is funded by the Canadian Institutes of Health Research.

Website: www.deprescribingnetwork.ca
Twitter: @DeprescribeNet
Facebook: @DeprescribingNetwork

SOURCE Canadian Deprescribing Network


These press releases may also interest you

at 08:45
The "China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032)" report has been added to ResearchAndMarkets.com's offering. This market research report provides key insights into the industry's rapid growth...

at 08:45
Lake Superior State University (LSSU), a rural, public college located in Michigan's upper peninsula, announced the launch of a new university-wide initiative designed to provide increased teletherapy and crisis support....

at 08:40
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, will showcase significant contributions in preclinical and translational oncology research at the American Association for Cancer Research (AACR) 2024...

at 08:38
HFA Architecture + Engineering has expanded its healthcare design team with the addition of Principal and Healthcare Practice Leader Paul Sabal (AIA, ACHA, NCARB, LEED AP).  Sabal is a registered architect and interior designer with more than four...

at 08:35
NanoVibronix, Inc. ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an...

at 08:35
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B...



News published on and distributed by: